EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSSFOG00015002180
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSSFOG00015006513
Gene Symbol: LOC108919370
3 Cross references
200 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSSFOG00015008829
Gene Symbol: LOC108928058
3 Cross references
411 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSFOG00015005345
Gene Symbol: LOC108938855
3 Cross references
308 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSSFOG00015023314
Gene Symbol: PGR
3 Cross references
192 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSSFOG00015021246
Gene Symbol: LOC108918744
3 Cross references
192 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSFOG00015006621
Gene Symbol: PTGDR2
3 Cross references
143 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSFOG00015004241
Gene Symbol: PTGDR2
3 Cross references
144 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSFOG00015016604
Gene Symbol: PTGDR2
3 Cross references
135 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSSFOG00015008694
Gene Symbol: PTGER1
3 Cross references
167 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSSFOG00015009700
Gene Symbol: PTGER2
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSSFOG00015014795
Gene Symbol: PTGER3
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).